CG Oncology Presents New Phase 2 Data With CG0070 in Combination With KEYTRUDA® (pembrolizumab) in Non-Muscle Invasive Bladder Cancer Unresponsive to Bacillus Calmette-Guérin

– 88% (n=28/32) of Evaluable Patients Achieved Complete Response at the Initial 3-Month Timepoint from the Phase 2 Clinical Trial of CG0070 in Combination with KEYTRUDA® (pembrolizumab) for NMIBC Unresponsive to BCG – – CG0070 in Combination with KEYTRUDA Was Well Tolerated with Promising Efficacy and Safety Data – IRVINE, Calif.–(BUSINESS WIRE)–#SITC2022—CG Oncology, Inc., an … [Read more…]

The Route Du Rhum Is Under Way: Alberto Bona’s Big Dream on Class40 IBSA Has Started

  SAINT-MALO, France–(BUSINESS WIRE)–#IBSA–After eleven months of planning and preparation, IBSA’s project Sailing into the Future. Together has begun its operational phase. In fact, the transoceanic regatta Route du Rhum started yesterday at 2:15 pm from Saint-Malo, Brittany, with western winds between 12 and 15 knots. Skipper Alberto Bona, aboard IBSA, is one of the … [Read more…]

Michael Gorton, Teladoc Founder, Recuro CEO Co-Authors Book with Jay Sanders, MD, Father of Telemedicine: Digital Medical Home – Telemedicine Ignites Creation of Precision Health

DALLAS–(BUSINESS WIRE)–#Digitalhealth—Recuro Health (Recuro), an integrated digital health solutions company that transitions the U.S. healthcare system from a reactive, disease-focused model to a population health, outcomes approach, announces the publication of Digital Medical Home: How the Telemedicine Revolution Ignited the Creation of Precision Health, co-authored by Michael Gorton, founder of Teladoc and chief executive officer … [Read more…]

The Worldwide Colorectal Procedure Industry is Expected to Reach $29.5 Billion by 2028 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Colorectal Procedure Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product, Surgery Type, End User, and Indication” report has been added to ResearchAndMarkets.com’s offering. The global colorectal procedure market is projected to reach US$ 29,550.98 million by 2028 from US$ 12,496.49 million in 2021. It is expected to register a … [Read more…]

Insights on The Changing World of Health and Wellness for the Family in 2022 with Focus on 23 Countries – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “The Changing World of Health and Wellness for the Family 2022 Report” report has been added to ResearchAndMarkets.com’s offering. When it comes to health and nutrition for the family, parents today are not the same as parents decades ago. Parenting has become a tipping point for stronger engagement in the world of health … [Read more…]

TimelyMD Named Top Workplace in North Texas

FORT WORTH, Texas–(BUSINESS WIRE)–#highered—TimelyMD, the leading virtual health and well-being solution in higher education, has been named a top workplace in North Texas by The Dallas Morning News. The top 100 honorees are chosen based solely on employee feedback. Each company took part in an employee survey conducted by Energage, which included topics such as … [Read more…]

HER2DX® Recognized by TIME as One of the Best Inventions of 2022

The publication bestows the recognition on inventions that tackle urgent issues in a creative manner. HER2DX® was highlighted in Times “Medical Care” category, which publicizes inventions that are successfully implemented in medical practice. HER2DX®️ is the first genomic test in the world specialized in HER2+ breast cancer and has been marketed by REVEAL GENOMICS® since … [Read more…]

AstraZeneca EVUSHELD Named on TIME’s List of the Best Inventions of 2022

WILMINGTON, Del.–(BUSINESS WIRE)–Today, TIME named AstraZeneca’s EVUSHELD (tixagevimab co-packaged with cilgavimab) on their 2022 list of Best Inventions. Their selection of EVUSHELD reflects its impact as the first and only long-acting monoclonal antibody to receive emergency use authorization in the US for the prevention of COVID-19 in immunocompromised people. “Immunocompromised individuals have lived a very … [Read more…]

AngelEye Health Announces Series B Funding to Support Company’s Rapid Growth

Latest Round of Investment in the Family Engagement Technology Company Led by Bradford Whitmore and Mountain Group Partners, with Participation by SeedtoB Capital and the Rash Family Office NASHVILLE, Tenn.–(BUSINESS WIRE)–#FamilyEngagement—AngelEye Health (“AngelEye” or the “Company”), a leading provider of patient and family engagement solutions for hospital neonatal, pediatric intensive care, and nursery units, today … [Read more…]

US Government Grants ModMed® a Patent

BOCA RATON, Fla.–(BUSINESS WIRE)–Healthcare technology innovator ModMed is pleased to announce that the US Government granted Patent No. 11,443,836 protecting some of the core functionality of its EHR system — a system designed to save clinicians time documenting exams and allows them to focus more on the patient in front of them. “This patent solidifies … [Read more…]